FDA — authorised 26 October 2009
- Application: BLA125326
- Marketing authorisation holder: NOVARTIS
- Status: supplemented
FDA authorised Arzerra on 26 October 2009
Yes. FDA authorised it on 26 October 2009; FDA has authorised it.
NOVARTIS holds the US marketing authorisation.